Insulin degludec/Insulin aspart (United Laboratories)
德谷胰岛素/门冬胰岛素（联邦制药）
Report date: 2026/05/26 20:00:28
Base Information
Drug NameInsulin degludec/Insulin aspart (United Laboratories)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesLianbang Biotechnology (Zhuhai Hengqin) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A